Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps

Bibliography

• Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Global alliance against chronic respiratory diseases. World Health Organisation; Geneva: 2007
   Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
   PubMed Web of Science ®Google Scholar
• Georgalas C, Vlastos I, Picavet V, et al. Is chronic rhinosinusitis related to allergic rhinitis in adults and children? Applying epidemiological guidelines for causation. Allergy 2014;69(7):828-33
   PubMed Web of Science ®Google Scholar
• Hellings PW, Prokopakis EP. Global airway disease beyond allergy. Curr Allergy Asthma Rep 2010;10(2):143-9
   PubMedGoogle Scholar
• Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003;58(8):691-706
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Incorvaia C, Scurati S, et al. Patient-related factors in rhinitis and asthma: the satisfaction with allergy treatment survey. Curr Med Res Opin 2011;27(5):1005-11
   PubMed Web of Science ®Google Scholar
• Fromer LM, Ortiz G, Ryan SF, et al. Insights on allergic rhinitis from the patient perspective. J Fam Pract 2012;61(2 Suppl):S16-22
   PubMed Web of Science ®Google Scholar
• Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy 2007;62(Suppl 85):9-16
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe. Allergy 2007;62(Suppl 85):17-25
   PubMed Web of Science ®Google Scholar
• Bousquet J, Anto JM, Demoly P, et al. Severe chronic allergic (and related) diseases: a uniform approach–a MeDALL–GA2LEN–ARIA position paper. Int Arch Allergy Immunol 2012;158(3):216-31
   PubMed Web of Science ®Google Scholar
• Bousquet PJ, Demoly P, Devillier P, et al. Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol 2013;160(4):393-400
   PubMed Web of Science ®Google Scholar
• Navarro A, Valero A, Rosales MJ, et al. Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis. J Investig Allergol Clin Immunol 2011;21(5):363-9
   PubMed Web of Science ®Google Scholar
• Demoly P, Bousquet PJ, Mesbah K, et al. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy 2013;43(8):881-8
   PubMed Web of Science ®Google Scholar
• Pitman R, Paracha N, Parker C, et al. Episode pattern and healthcare utilisation in patients with seasonal allergic rhinitis. 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI). Geneva, Switzerland: ALLERGY 2012. 342-2
   Google Scholar
• Valovirta E, Ryan D. Patient adherence to allergic rhinitis treatment: results from patient surveys. Medscape J Med 2008;10(10):247
   PubMedGoogle Scholar
• Anolik R. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008;100(3):264-71
   PubMed Web of Science ®Google Scholar
• Esteitie R, deTineo M, Naclerio RM, et al. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol 2010;105(2):155-61
   PubMedGoogle Scholar
• Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):S147-334
   PubMed Web of Science ®Google Scholar
• Dykewicz MS. 7. Rhinitis and sinusitis. J Allergy Clin Immunol 2003;111(2 Suppl):S520-9
   PubMedGoogle Scholar
• Arbes SJJr, Gergen PJ, Elliott L, et al. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116(2):377-83
   PubMed Web of Science ®Google Scholar
• D’Amato G, Lobefalo G. Allergenic pollens in the southern Mediterranean area. J Allergy Clin Immunol 1989;83(1):116-22
   PubMedGoogle Scholar
• Platts-Mills TA, Hayden ML, Chapman MD, et al. Seasonal variation in dust mite and grass-pollen allergens in dust from the houses of patients with asthma. J Allergy Clin Immunol 1987;79(5):781-91
   PubMed Web of Science ®Google Scholar
• Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122(2 Suppl):S1-84
   PubMed Web of Science ®Google Scholar
• Bousquet J, Clark TJ, Hurd S, et al. GINA guidelines on asthma and beyond. Allergy 2007;62(2):102-12
   PubMed Web of Science ®Google Scholar
• Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010;126(5):926-38
   PubMed Web of Science ®Google Scholar
• Expert panel report 3: Guidelines for the diagnosis and management of asthma. National asthma education and prevention program. National Heart, Lung and Blood Institute. US Department Of Health And Human Services; 2007
   Google Scholar
• Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007;62(4):367-72
   PubMed Web of Science ®Google Scholar
• Bousquet J, Neukirch F, Bousquet PJ, et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 2006;117(1):158-62
   PubMed Web of Science ®Google Scholar
• del Cuvillo A, Montoro J, Bartra J, et al. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort study. Rhinology 2010;48(2):201-5
   PubMedGoogle Scholar
• Jauregui I, Davila I, Sastre J, et al. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: the PEDRIAL study. Pediatr Allergy Immunol 2011;22(4):388-92
   PubMed Web of Science ®Google Scholar
• Virchow JC, Kay S, Demoly P, et al. Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients–an observational, cross sectional study in four countries in Europe. J Med Econ 2011;14(3):305-14
   PubMedGoogle Scholar
• Bousquet J, Bachert C, Canonica GW, et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol 2009;124(3):428-33
   PubMed Web of Science ®Google Scholar
• Bousquet PJ, Bachert C, Canonica GW, et al. Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol. United States 2010:126(3):666-8. e1-5
   Google Scholar
• Brasier AR, Victor S, Boetticher G, et al. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. J Allergy Clin Immunol 2008;121(1):30-7; e6
   PubMedGoogle Scholar
• Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368(9537):804-13
   PubMed Web of Science ®Google Scholar
• Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126(3):466-76
   PubMed Web of Science ®Google Scholar
• Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 2008;38(1):19-42
   PubMed Web of Science ®Google Scholar
• Ratner PH, Paull BR, Findlay SR, et al. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily. J Allergy Clin Immunol 1992;90(3 Pt 1):285-91
   PubMedGoogle Scholar
• Mandl M, Nolop K, Lutsky BN. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group. Ann Allergy Asthma Immunol 1997;79(4):370-8
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Gallet CL, Jalowayski AA, et al. Triamcinolone acetonide and fluticasone propionate aqueous nasal sprays significantly improve nasal airflow in patients with seasonal allergic rhinitis. Allergy Asthma Proc 2004;25(1):53-8
   PubMedGoogle Scholar
• Okubo K, Nakashima M, Miyake N, et al. Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis. Allergy Asthma Proc 2009;30(1):84-94
   PubMedGoogle Scholar
• Maspero JF, Walters RD, Wu W, et al. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Allergy Asthma Proc 2010;31(6):483-92
   PubMedGoogle Scholar
• Bielory L, Chun Y, Bielory BP, et al. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis. Allergy 2011;66(5):686-93
   PubMedGoogle Scholar
• Rosenwasser LJ, Mahr T, Abelson MB, et al. A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis. Allergy Asthma Proc 2008;29(6):644-53
   PubMed Web of Science ®Google Scholar
• Price D, Kemp L, Sims E, et al. Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthma. Prim Care Respir J 2010;19(3):266-73
   PubMedGoogle Scholar
• Bernstein JA. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. Curr Med Res Opin 2007;23(10):2441-52
   PubMed Web of Science ®Google Scholar
• Carr WW, Ratner P, Munzel U, et al. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis. Allergy Asthma Proc 2012;33(6):450-8
   PubMedGoogle Scholar
• Bisgaard H, Skoner D, Boza ML, et al. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol 2009;44(6):568-79
   PubMed Web of Science ®Google Scholar
• Li AM, Abdullah VJ, Tsen CS, et al. Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis–a randomized placebo-controlled study. Pediatr Pulmonol 2009;44(11):1085-92
   PubMed Web of Science ®Google Scholar
• Milgrom H, Biondi R, Georgitis JW, et al. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol 1999;83(2):105-11
   PubMed Web of Science ®Google Scholar
• Horak F, Zieglmayer P, Zieglmayer R, et al. A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber. Ann Allergy Asthma Immunol 2009;102(2):116-20
   PubMed Web of Science ®Google Scholar
• Varghese M, Glaum MC, Lockey RF. Drug-induced rhinitis. Clin Exp Allergy 2010;40(3):381-4
   PubMed Web of Science ®Google Scholar
• Ratner PH, van Bavel JH, Martin BG, et al. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract 1998;47(2):118-25
   PubMed Web of Science ®Google Scholar
• Dretzke J, Meadows A, Novielli N, et al. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol 2013;131(5):1361-6
   PubMed Web of Science ®Google Scholar
• Marogna M, Spadolini I, Massolo A, et al. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol 2010;126(5):969-75
   PubMed Web of Science ®Google Scholar
• Des Roches A, Paradis L, Menardo JL, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997;99(4):450-3
   PubMed Web of Science ®Google Scholar
• Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62(8):943-8
   PubMed Web of Science ®Google Scholar
• Rouve S, Didier A, Demoly P, et al. Numeric score and visual analog scale in assessing seasonal allergic rhinitis severity. Rhinology 2010;48(3):285-91
   PubMedGoogle Scholar
• Juniper EF, Thompson AK, Ferrie PJ, et al. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999;104(2 Pt 1):364-9
   PubMedGoogle Scholar
• Demoly P, Jankowski R, Chassany O, et al. Validation of a self-questionnaire for assessing the control of allergic rhinitis. Clin Exp Allergy 2011;41(6):860-8
   PubMedGoogle Scholar
• Schatz M, Meltzer EO, Nathan R, et al. Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol 2010;104(2):118-24
   PubMedGoogle Scholar
• Price D, Bousquet J, Pitman D, et al. Sub-optimal control of allergic rhinitis: the need for a new and more effective treatment option. 32nd Congress of the European Academy of Allergy and Clinical Immunology (EAACI). Milan, Italy; 2013
   Google Scholar
• Derendorf H, Munzel U, Petzold U, et al. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray. Br J Clin Pharmacol 2012;74(1):125-33
   PubMed Web of Science ®Google Scholar
• Andrews CP, Ratner PH, Ehler BR, et al. The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitis. Ann Allergy Asthma Immunol 2013;111(1):9-13
   PubMedGoogle Scholar
• Bousquet J, Knani J, Hejjaoui A, et al. Heterogeneity of atopy. I. Clinical and immunologic characteristics of patients allergic to cypress pollen. Allergy 1993;48(3):183-8
   PubMedGoogle Scholar
• Hampel FC, Ratner PH, Van Bavel J, et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol 2010;105(2):168-73
   PubMed Web of Science ®Google Scholar
• Meltzer E, Ratner P, Bachert C, et al. Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis. Int Arch Allergy Immunol 2013;161(4):369-77
   PubMed Web of Science ®Google Scholar
• EMA guideline: guideline on the clinical development of medicinal products for the treatment of allergic rhinoconjunctivitis. 2004. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003554.pdf [Last accessed 28 July 2014]
   Google Scholar
• Carr W, Bernstein J, Lieberman P, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol 2012;129(5):1282-9; e10
   PubMed Web of Science ®Google Scholar
• Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006;368(9537):744-53
   PubMed Web of Science ®Google Scholar
• Verriere VA, Hynes D, Faherty S, et al. Rapid effects of dexamethasone on intracellular pH and Na+/H+ exchanger activity in human bronchial epithelial cells. J Biol Chem 2005;280(43):35807-14
   PubMedGoogle Scholar
• Price D, Shah S, Bhatia S, et al. A New Therapy (MP29-02) Is Effective For The Long-Term Treatment Of Chronic Rhinitis. J Investig Allergol Clin Immunol 2013;23(7):495-503
   PubMed Web of Science ®Google Scholar
• Berger WE, Shah S, Lieberman P, et al. Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis. J Allergy Clin Immunol Pract 2014;2(2):179-85
   PubMed Web of Science ®Google Scholar
• Snapinn SM, Jiang Q. Responder analyses and the assessment of a clinically relevant treatment effect. Trials 2007;8:31
   PubMed Web of Science ®Google Scholar
• FDA draft guidance or industry patient-reported outcome measures: use in medicinal product development to support labelling claims. 2009. Available from: http://wwwfdagov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282pdf [Last accessed 28 July 2014]
   Google Scholar
• Muller V, Galffy G, Eszes N, et al. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med 2011;11:40
   PubMed Web of Science ®Google Scholar
• Schueepp KG, Devadason SG, Roller C, et al. Aerosol delivery of nebulised budesonide in young children with asthma. Respir Med 2009;103(11):1738-45
   PubMedGoogle Scholar
• Pedersen S, Warner J, Wahn U, et al. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children. Pediatrics 2002;109(6):e92
   Google Scholar
• Busse WW, Brazinsky S, Jacobson K, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999;104(6):1215-22
   PubMed Web of Science ®Google Scholar
• Salapatek AM, Lee J, Patel D, et al. Solubilized nasal steroid (CDX-947) when combined in the same solution nasal spray with an antihistamine (CDX-313) provides improved, fast-acting symptom relief in patients with allergic rhinitis. Allergy Asthma Proc 2011;32(3):221-9
   PubMedGoogle Scholar
• Hellings PW, Dobbels F, Denhaerynck K, et al. Explorative study on patient’s perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis. Clin Transl Allergy 2012;2(1):9
   PubMedGoogle Scholar